Related Experiment Video
Updated: Dec 8, 2025

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
Published on: October 18, 2011
Stem cell therapy for Alzheimer's disease
Xin-Yu Liu1, Lin-Po Yang1, Lan Zhao1
1First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China.
Abstract:
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by memory loss and cognitive impairment. It is caused by synaptic failure and excessive accumulation of misfolded proteins. To date, almost all advanced clinical trials on specific AD-related pathways have failed mostly due to a large number of neurons lost in the brain of patients with AD. Also, currently available drug candidates intervene too late. Stem cells have improved characteristics of self-renewal, proliferation, differentiation, and recombination with the advent of stem cell technology and the transformation of these cells into different types of central nervous system neurons and glial cells. Stem cell treatment has been successful in AD animal models. Recent preclinical studies on stem cell therapy for AD have proved to be promising. Cell replacement therapies, such as human embryonic stem cells or induced pluripotent stem cell-derived neural cells, have the potential to treat patients with AD, and human clinical trials are ongoing in this regard. However, many steps still need to be taken before stem cell therapy becomes a clinically feasible treatment for human AD and related diseases. This paper reviews the pathophysiology of AD and the application prospects of related stem cells based on cell type.
Insights
Stem cell therapy shows promise for Alzheimer's disease (AD) by potentially replacing lost neurons. While successful in animal models, further research is needed for clinical application in humans.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Stem Cell Biology
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder causing memory loss and cognitive decline.
- Pathophysiology involves synaptic failure and protein misfolding, with significant neuron loss limiting current treatment efficacy.
- Existing drug candidates often intervene too late in the disease progression.
Purpose of the Study:
- To review the pathophysiology of Alzheimer's disease.
- To explore the application prospects of stem cell therapy for AD based on cell type.
- To assess the potential of stem cells in treating AD and related neurological disorders.
Main Methods:
- Review of preclinical studies and recent advancements in stem cell technology.
- Analysis of stem cell differentiation into central nervous system neurons and glial cells.
- Examination of ongoing human clinical trials for stem cell therapies in AD.
Main Results:
- Stem cell treatments have demonstrated success in Alzheimer's disease animal models.
- Preclinical studies indicate promising therapeutic potential for stem cell therapy in AD.
- Cell replacement strategies using stem cells offer a potential avenue for treating AD patients.
Conclusions:
- Stem cell therapy holds significant potential for treating Alzheimer's disease, particularly through cell replacement.
- Human clinical trials are underway, but further development is required for widespread clinical feasibility.
- Understanding stem cell types and their application is crucial for advancing AD treatment.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
iPS Cell Differentiation
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Stem Cell Culture
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

